questionsmedicales.fr
Maladies du système immunitaire
Maladies auto-immunes
Vascularites associées aux anticorps anti-cytoplasme des neutrophiles
Syndrome de Churg-Strauss
Syndrome de Churg-Strauss : Questions médicales fréquentes
Diagnostic
5
Syndrome de Churg-Strauss
Vasculite
Biopsie
Eosinophiles
Inflammation
Tests sanguins
Imagerie médicale
IRM
Radiographie
Symptômes
Respiration
Neurologie
Maladies auto-immunes
Vasculites
Diagnostic différentiel
Symptômes
5
Asthme
Toux
Douleurs thoraciques
Éruptions cutanées
Nodules
Ulcères
Maux de tête
Engourdissements
Troubles de la vision
Cœur
Reins
Système nerveux central
Variabilité des symptômes
Patients
Syndrome de Churg-Strauss
Prévention
5
Prévention
Allergènes
Syndrome de Churg-Strauss
Médicaments
Sensibilité
Syndrome de Churg-Strauss
Allergies
Asthme
Gestion des symptômes
Vaccinations
Infections
Prévention
Suivi médical
Complications
Prévention
Traitements
5
Corticostéroïdes
Immunosuppresseurs
Traitement
Efficacité du traitement
Suivi médical
Syndrome de Churg-Strauss
Effets secondaires
Ostéoporose
Corticostéroïdes
Surveillance médicale
Ajustement du traitement
Complications
Traitements biologiques
Réfractaire
Syndrome de Churg-Strauss
Complications
5
Complications
Atteintes pulmonaires
Atteintes cardiaques
Complications neurologiques
AVC
Syndrome de Churg-Strauss
Gestion des complications
Traitements spécifiques
Suivi médical
Prévention des complications
Traitement précoce
Syndrome de Churg-Strauss
Qualité de vie
Complications
Syndrome de Churg-Strauss
Facteurs de risque
5
Facteurs de risque
Asthme
Eosinophilie
Âge
Syndrome de Churg-Strauss
Adultes
Sexe
Syndrome de Churg-Strauss
Prévalence
Facteurs environnementaux
Allergènes
Médicaments
Antécédents familiaux
Maladies auto-immunes
Syndrome de Churg-Strauss
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Churg-Strauss : Questions médicales les plus fréquentes",
"headline": "Syndrome de Churg-Strauss : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome de Churg-Strauss : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-25",
"dateModified": "2026-02-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome de Churg-Strauss"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vascularites associées aux anticorps anti-cytoplasme des neutrophiles",
"url": "https://questionsmedicales.fr/mesh/D056648",
"about": {
"@type": "MedicalCondition",
"name": "Vascularites associées aux anticorps anti-cytoplasme des neutrophiles",
"code": {
"@type": "MedicalCode",
"code": "D056648",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111.193"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Churg-Strauss",
"alternateName": "Churg-Strauss Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D015267",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ashok Kumar",
"url": "https://questionsmedicales.fr/author/Ashok%20Kumar",
"affiliation": {
"@type": "Organization",
"name": "Internal Medicine, Max Smart Super Specialty Hospital, Saket, New Delhi, IND."
}
},
{
"@type": "Person",
"name": "Giacomo Emmi",
"url": "https://questionsmedicales.fr/author/Giacomo%20Emmi",
"affiliation": {
"@type": "Organization",
"name": "Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: giacomo.emmi@unifi.it."
}
},
{
"@type": "Person",
"name": "Augusto Vaglio",
"url": "https://questionsmedicales.fr/author/Augusto%20Vaglio",
"affiliation": {
"@type": "Organization",
"name": "Deptartment of Biomedical, Experimental and Clinical Sciences \"Mario Serio\", University of Firenze, Firenze, Italy."
}
},
{
"@type": "Person",
"name": "Xavier Puéchal",
"url": "https://questionsmedicales.fr/author/Xavier%20Pu%C3%A9chal",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France."
}
},
{
"@type": "Person",
"name": "Luc Mouthon",
"url": "https://questionsmedicales.fr/author/Luc%20Mouthon",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Anesthesia management in a patient with Churg-Strauss syndrome in the ambulatory setting: A case report.",
"datePublished": "2023-09-04",
"url": "https://questionsmedicales.fr/article/37666453",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.redare.2022.03.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cardiac Mass and Cerebrovascular Accident as Primary Manifestations of Churg-Strauss Syndrome.",
"datePublished": "2023-11-01",
"url": "https://questionsmedicales.fr/article/38310427",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34172/aim.2023.97"
}
},
{
"@type": "ScholarlyArticle",
"name": "Looking Beyond Pneumonia and Asthma in India: An Interesting Case of Churg-Strauss Syndrome.",
"datePublished": "2024-08-08",
"url": "https://questionsmedicales.fr/article/39246977",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.66416"
}
},
{
"@type": "ScholarlyArticle",
"name": "Navigating the complexity of Churg-Strauss syndrome presenting as acute abdomen: a comprehensive review and case report.",
"datePublished": "2024-02-14",
"url": "https://questionsmedicales.fr/article/38576936",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MS9.0000000000001827"
}
},
{
"@type": "ScholarlyArticle",
"name": "EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP).",
"datePublished": "2024-03-21",
"url": "https://questionsmedicales.fr/article/38549809",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5414/ALX02475E"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vascularites associées aux anticorps anti-cytoplasme des neutrophiles",
"item": "https://questionsmedicales.fr/mesh/D056648"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndrome de Churg-Strauss",
"item": "https://questionsmedicales.fr/mesh/D015267"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome de Churg-Strauss - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome de Churg-Strauss",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome de Churg-Strauss",
"description": "Comment diagnostique-t-on le syndrome de Churg-Strauss ?\nQuels tests sanguins sont utilisés pour le diagnostic ?\nLes imageries sont-elles nécessaires pour le diagnostic ?\nQuels symptômes cliniques sont observés ?\nLe syndrome peut-il être confondu avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D015267#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome de Churg-Strauss",
"description": "Quels sont les symptômes respiratoires du syndrome ?\nY a-t-il des symptômes cutanés associés ?\nQuels symptômes neurologiques peuvent survenir ?\nLe syndrome affecte-t-il d'autres organes ?\nLes symptômes varient-ils d'un patient à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D015267#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome de Churg-Strauss",
"description": "Peut-on prévenir le syndrome de Churg-Strauss ?\nLes patients doivent-ils éviter certains médicaments ?\nComment gérer les allergies pour prévenir les symptômes ?\nLes vaccinations sont-elles recommandées ?\nLe suivi médical régulier aide-t-il à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D015267#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome de Churg-Strauss",
"description": "Quels traitements sont utilisés pour le syndrome ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLe traitement nécessite-t-il une surveillance régulière ?\nDes traitements alternatifs existent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D015267#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome de Churg-Strauss",
"description": "Quelles sont les complications possibles du syndrome ?\nLe syndrome peut-il entraîner des problèmes neurologiques ?\nComment les complications sont-elles gérées ?\nLes complications peuvent-elles être évitées ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D015267#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome de Churg-Strauss",
"description": "Quels sont les facteurs de risque du syndrome ?\nL'âge influence-t-il le risque de développer le syndrome ?\nLe sexe joue-t-il un rôle dans le risque ?\nLes facteurs environnementaux sont-ils impliqués ?\nLes antécédents familiaux influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D015267#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le syndrome de Churg-Strauss ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des critères cliniques, des analyses sanguines et des biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests pour détecter des éosinophiles élevés et des marqueurs inflammatoires sont effectués."
}
},
{
"@type": "Question",
"name": "Les imageries sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des imageries comme la radiographie ou l'IRM peuvent aider à évaluer les organes touchés."
}
},
{
"@type": "Question",
"name": "Quels symptômes cliniques sont observés ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes respiratoires, cutanés et neurologiques sont souvent présents lors du diagnostic."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il être confondu avec d'autres maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec d'autres vasculites ou maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes respiratoires du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'asthme, la toux, et des douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées, des nodules et des ulcères peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Quels symptômes neurologiques peuvent survenir ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maux de tête, des engourdissements et des troubles de la vision peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Le syndrome affecte-t-il d'autres organes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut toucher le cœur, les reins et le système nerveux central."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'un patient à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la combinaison des symptômes peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le syndrome de Churg-Strauss ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais éviter les allergènes peut aider."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils éviter certains médicaments ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent déclencher des symptômes chez les patients sensibles."
}
},
{
"@type": "Question",
"name": "Comment gérer les allergies pour prévenir les symptômes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion adéquate des allergies et de l'asthme peut réduire les risques de symptômes."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles recommandées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent être recommandées pour prévenir les infections."
}
},
{
"@type": "Question",
"name": "Le suivi médical régulier aide-t-il à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier permet de détecter précocement les complications."
}
},
{
"@type": "Question",
"name": "Quels traitements sont utilisés pour le syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes et les immunosuppresseurs sont les principaux traitements."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la plupart des patients répondent bien aux traitements, mais un suivi est nécessaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent causer des effets secondaires comme l'ostéoporose."
}
},
{
"@type": "Question",
"name": "Le traitement nécessite-t-il une surveillance régulière ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière est essentielle pour ajuster le traitement et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Des traitements alternatifs existent-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements biologiques peuvent être envisagés pour certains patients réfractaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du syndrome ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des atteintes pulmonaires, cardiaques et rénales."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il entraîner des problèmes neurologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications neurologiques comme des AVC peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent souvent des traitements spécifiques et un suivi intensif."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et approprié."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du syndrome ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'asthme, de rhinite allergique et d'éosinophilie sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de développer le syndrome ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le syndrome est plus fréquent chez les adultes jeunes à moyens d'âge."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le syndrome est légèrement plus fréquent chez les hommes que chez les femmes."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux sont-ils impliqués ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains allergènes ou médicaments peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies auto-immunes peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 14/02/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Internal Medicine, Max Smart Super Specialty Hospital, Saket, New Delhi, IND.
Publications dans "Syndrome de Churg-Strauss" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: giacomo.emmi@unifi.it.
Publications dans "Syndrome de Churg-Strauss" :
2 publications dans cette catégorie
Affiliations :
Deptartment of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Firenze, Firenze, Italy.
Publications dans "Syndrome de Churg-Strauss" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France.
Publications dans "Syndrome de Churg-Strauss" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France.
Publications dans "Syndrome de Churg-Strauss" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France.
Publications dans "Syndrome de Churg-Strauss" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France.
Publications dans "Syndrome de Churg-Strauss" :
2 publications dans cette catégorie
Publications dans "Syndrome de Churg-Strauss" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA. Electronic address: https://twitter.com/LeenAlblaihed.
Publications dans "Syndrome de Churg-Strauss" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, Elisabeth TweeSteden Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, the Netherlands; Department of Emergency Medicine, University of Maryland School of Medicine, MD, USA. Electronic address: m.huisintveld@etz.nl.
Publications dans "Syndrome de Churg-Strauss" :
1 publication dans cette catégorie
Affiliations :
Department of Surgery, University Hospital Galway, Galway, IRL.
Publications dans "Syndrome de Churg-Strauss" :
1 publication dans cette catégorie
Affiliations :
Department of Surgery, University Hospital Galway, Galway, IRL.
Publications dans "Syndrome de Churg-Strauss" :
1 publication dans cette catégorie
Affiliations :
Department of Surgery, University Hospital Galway, Galway, IRL.
Publications dans "Syndrome de Churg-Strauss" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology, University Hospital Galway, Galway, IRL.
Publications dans "Syndrome de Churg-Strauss" :
1 publication dans cette catégorie
Affiliations :
Department of Surgery, University Hospital Galway, Galway, IRL.
Publications dans "Syndrome de Churg-Strauss" :
1 publication dans cette catégorie
Affiliations :
Department of Family Medicine, Private Hurremsultan Hospital, Istanbul, Turkey.
Publications dans "Syndrome de Churg-Strauss" :
1 publication dans cette catégorie
Affiliations :
Centro Hospitalar Tondela-Viseu, Portugal.
Publications dans "Syndrome de Churg-Strauss" :
1 publication dans cette catégorie
Affiliations :
Centro Hospitalar Tondela-Viseu, Portugal.
Publications dans "Syndrome de Churg-Strauss" :
1 publication dans cette catégorie
Affiliations :
Centro Hospitalar Tondela-Viseu, Portugal.
Publications dans "Syndrome de Churg-Strauss" :
1 publication dans cette catégorie
Affiliations :
Centro Hospitalar Tondela-Viseu, Portugal.
Publications dans "Syndrome de Churg-Strauss" :
Eosinophilic granulomatosis with polyangiitis (EGPA), also known as Churg-Strauss syndrome, is a rare type of vasculitis with multisystemic involvement. Very few authors have described the anaesthesia...
Churg-Strauss syndrome (CSS), recently named eosinophilic granulomatosis with polyangiitis (EGPA), is a rare form of systemic vasculitis with extravascular granulomas occurring in patients with asthma...
Churg-Strauss syndrome is a rare multisystem disorder characterized by asthma, eosinophilia, and vasculitis. The patient presented with prolonged fever, cough with blood-stained sputum, weight loss, p...
Churg-Strauss syndrome (CSS) is a rare multisystemic condition characterized by asthma, blood and tissue eosinophilia, and vasculitis. The purpose of this work is to present a detailed overview of CSS...
The authors report a case of a 40-year-old woman with CSS who had peripheral eosinophilia, small vessel vasculitis, and bronchial asthma. Diagnosed with symmetric polyarthritis six months ago, experie...
CSS can cause gastrointestinal symptoms including stomach pain, diarrhoea, mucosal ulcers, rectal bleeding, and bowel perforations. Corticosteroids and immunosuppressives are routinely used in treatme...
CSS is a rare condition, with an annual incidence of 2.4 per million and a prevalence of 1.3 per 100 000. The illness typically presents with necrotizing vasculitis, extravascular granulomas, and eosi...
Eosinophilic granulomatosis with polyangiitis (EGPA) was formerly known as Churg-Strauss syndrome. The condition is characterized by disseminated necrotizing vasculitis with extravascular granulomas a...
Immunological background, diagnosis, and therapy of EGPA were identified through literature searches in Medline, PubMed, as well as national and international studies (ClinicalTrials.gov) and the Coch...
In cases of deteriorating general health with previously known eosinophilic inflammation of the upper and lower airways, EGPA and its interdisciplinary investigation should be considered. Various type...
Characterization of mucosal airway inflammation through biomarker determination is meaningful and occasionally makes the difference for targeted therapy....
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of disorders characterized by necrotizing inflammation of small- and medium-sized blood vessels and the presence of ci...
Herein, we describe a case of MLS in a 51-year-old woman, never-smoker, affected by EGPA, presenting exclusively with leukocytosis and elevated concentrations of acute-phase proteins, without any resp...
To the best of our knowledge, this is the first detailed description of MLS in EGPA completely resolved through FOB. Identification of MLS in EGPA appears essential as prognosis, longitudinal manageme...
When researchers and scholars claim their work is based on a philosophical idea or a philosopher's corpus of ideas (and theory/theorist can be substituted for philosophy/philosopher), and when 'basing...
The left bundle branch block (LBBB) is a strong predictor of response to cardiac resynchronization therapy (CRT). However, a significant number of patients do not respond to the treatment. The study s...
This study is a retrospective analysis of prospectively collected data on heart failure (HF) patients with LBBB admitted for CRT implantation. Patients were divided into two groups according to the fu...
The study included 82 patients with ischaemic (ICM) and non-ischaemic (NICM) cardiomyopathy [46 (56%) with St-LBBB and 36 (44%) with non-St-LBBB]. Patients with St-LBBB showed higher CRT response rate...
Patients with NICM and St-LBBB present the greatest benefit concerning CRT response, HF hospitalizations, VA events and mortality. Although St-LBBB criteria seem to improve patient selection for CRT, ...
This study examined the relationship between age at diagnosis and disease characteristics and damage in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)....
Analysis of a prospective longitudinal cohort of patients with granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic GPA (EGPA) in the Vasculitis Clinical Research C...
Analysis included data from 1020 patients with GPA/MPA and 357 with EGPA. Female predominance in GPA/MPA decreased with age at diagnosis. AAV in childhood was more often GPA and proteinase 3-ANCA posi...
Age at diagnosis is associated with clinical characteristics in AAV. Although VDI and AVID scores increase with age at diagnosis, this is driven by non-disease-specific damage items....
Although the high disease burden associated with eosinophilic granulomatosis with polyangiitis (EGPA) has been established, the disease burden in patients initiating mepolizumab in real-world practice...
This was a database study (GSK study ID: 214156) of US patients (≥12 years old) with EGPA and ≥1 mepolizumab claim (index date) identified from the Merative MarketScan Commercial and Medicare Suppleme...
In the 103 patients included (mean age, 51.1 years; 63.1% female), the most common manifestations were asthma (89.3%), chronic sinusitis (57.3%), and allergic rhinitis (43.7%). In total, 91.3% of pati...
Before initiating mepolizumab, a substantial real-world EGPA disease burden is evident for patients, with resulting impact on health care systems, and indicative of unmet medical needs. Mepolizumab tr...